GRAL GRAIL, Inc.

NASDAQ
$67.87

GRAIL, Inc. (GRAL) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $2.84 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.2% since its last earnings release on August 5, 2026.

GRAIL Beat Consensus Estimates
Wednesday, August 5, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($2.84)
Rev est $42.68M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $69.17

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About GRAIL, Inc.

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured.

Sector

Healthcare

Industry

Medical Labs & Research